LNA Santé SA announced that it will receive an equity round of funding on November 23, 2021. The transaction included participation from new investors Groupe Siparex, Unexo, SCR, Sodero Gestion, BNP Paribas Développement SA, SCR, SMA Group Limited, and existing investor Financiere Vertavienne 44.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.24 EUR | +0.31% | +0.21% | -4.28% |
Mar. 28 | LNA Santé: 9% drop in annual RNPG | CF |
Feb. 12 | LNA Santé: LNA Ensemble exceeds 10% of voting rights | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.28% | 210M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- LNA Stock
- News LNA Santé
- LNA Santé SA announced that it expects to receive funding from Groupe Siparex, Unexo, SCR, Sodero Gestion, BNP Paribas Développement SA, SCR, SMA Group Limited, Financiere Vertavienne 44